| Code | 2859F | ||||||||||
| MA number | 44/0066/26-S | ||||||||||
| Product Form: | tbl flm 30x2,5 mg (blis.PVC/PE/PVDC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/PE/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 06.03.2026 |
| Validity: | 06.03.2031 |
| SPC: |
SPC_Letrozol Sandoz d.d. 2,5 mg_tbl flm_03/2026_REG.pdf
|
| PIL: |
PIL_Letrozol Sandoz d.d. 2,5 mg_03.2026.pdf
|
| Safety feature | Yes |
| Data update: | 23.03.2026 |
